Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations

Roflumilast is given as an add-on to inhalation medication in patients with chronic obstructive pulmonary disease (COPD) and chronic bronchitis. Animal experiments have documented deleterious effects of roflumilast in bacterial infections, but trials have not reported the risk of bacterial infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Alispahic, Imane Achir, Sørensen, Rikke, Eklöf, Josefin, Sivapalan, Pradeesh, Løkke, Anders, Seersholm, Niels, Vestergaard, Jakob Hedemark, Jensen, Jens-Ulrik Stæhr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291283/
https://www.ncbi.nlm.nih.gov/pubmed/32408645
http://dx.doi.org/10.3390/jcm9051442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291283/
https://www.ncbi.nlm.nih.gov/pubmed/32408645
http://dx.doi.org/10.3390/jcm9051442

Ejemplares similares